
BioCardia Inc. (BCDA) Earnings Dates & Reports
BioCardia Inc. (BCDA) Most Recent Earnings
Report Date
Period EndingQ3 2025
Est. EPS-$0.25
Actual EPS-$0.24
EarningsBeat
BioCardia Inc. (BCDA) Earnings
View the latest BioCardia Inc. (BCDA) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in BioCardia Inc. (BCDA)
Order type
Buy in
Order amount
Est. shares
0 shares
BioCardia Inc. (BCDA) Earnings per Share (EPS) History
Signup for full accessBrowse free
BioCardia Inc. (BCDA) Latest Earnings
The value each BCDA share was expected to gain vs. the value each share gained.
BioCardia Inc. (BCDA) reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of -$0.24. This exceeded analysts' expectations of -$0.25 by 4.00%, marking a Beat.
For comparison, BioCardia Inc. reported EPS of -$0.61 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.20.
BioCardia Inc. (BCDA) Earnings History
BioCardia Inc. (BCDA) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the BioCardia Inc.’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
BioCardia Inc. (BCDA) Earnings FAQs
BioCardia Inc. (BCDA) last reported earnings on Nov 12, 2025 for Q3 2025, posting an EPS of -$0.24, which Beat the estimate of -$0.25 by 4.00%.
For Q3 2025, BioCardia Inc. (BCDA) reported an EPS of -$0.24, exceeding analysts' estimate of -$0.25 by 4.00%.
For Q3 2025, BioCardia Inc. (BCDA) Beat expectations with an actual EPS of -$0.24 vs. an estimated EPS of -$0.25.
Following the last earnings report on Nov 12, 2025, BioCardia Inc. (BCDA)'s stock price moved — from — to —.
The next BioCardia Inc. (BCDA) earnings call is scheduled for Mar. 25, 2026, where executives will discuss financial results and outlook.